SenesTech, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
GLENBROOK CAPITAL MANAGEMENT purchased 983,804 indirectly-held shares of SenesTech, Inc. (SNES) at an average of $0.72 ($0.63–$0.77, $0.71M total) across 3 trades over 2026-10-15 to 2026-10-19.
Glenbrook Capital Management acquired over 30% of SenesTech (SNES), criticizing shareholder dilution and proposing strategic changes. The firm cited 40% revenue growth in Q3 and a $4M run rate. Glenbrook seeks to align management interests with shareholders and may increase its stake.
SenesTech reported an 88% reduction in rat activity in a Chicago pilot using its Evolve® Rat Birth Control™. The company also announced record Q3 2026 revenue of $1.1 million, up 40% sequentially and 55% year-over-year. Evolve is now deployed in six Chicago areas, targeting reproduction to reduce rodent populations sustainably.
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning SNES (SenesTech, Inc.). Coverage has skewed bullish: 6 bullish, 2 neutral, and 1 bearish.
Recent SNES coverage spans insider activity, earnings and mergers & acquisitions.
In the last 30 days, SNES insiders filed 4 SEC Form 4 transactions — 4 purchases ($707K) and no sales. The most active reporter was GLENBROOK CAPITAL MANAGEMENT with 3 filings.
The insider purchase may signal confidence in SenesTech, potentially supporting the stock price in the short term.
Stake acquisition may reduce dilution risk and signal strategic support, likely supporting the stock.
Positive operational results may boost investor confidence and drive short‑term buying pressure.
Preliminary revenue milestone and guidance on e-commerce and B2B momentum can support near-term sentiment, but the lack of audited numbers limits conviction until the definitive release.
The company posted its first $1M+ quarterly revenue, indicating growth momentum.
AlphAI scores every news story that mentions SNES with an AI model for sentiment and relevance, and aggregates insider trades from SenesTech, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
GLENBROOK CAPITAL MANAGEMENT purchased 983,804 indirectly-held shares of SenesTech, Inc. (SNES) at an average of $0.72 ($0.63–$0.77, $0.71M total) across 3 trades over 2026-10-15 to 2026-10-19.
1 min readGlenbrook Capital Management acquired over 30% of SenesTech (SNES), criticizing shareholder dilution and proposing strategic changes. The firm cited 40% revenue growth in Q3 and a $4M run rate. Glenbrook seeks to align management interests with shareholders and may increase its stake.
2 min readSenesTech reported an 88% reduction in rat activity in a Chicago pilot using its Evolve® Rat Birth Control™. The company also announced record Q3 2026 revenue of $1.1 million, up 40% sequentially and 55% year-over-year. Evolve is now deployed in six Chicago areas, targeting reproduction to reduce rodent populations sustainably.
2 min readSenesTech, Inc. (NASDAQ:SNES) reported preliminary Q3 2026 revenue exceeding $1 million for the first time. The company expects continued growth in e-commerce and B2B sectors, with definitive results to be released in November. SenesTech develops rodent birth control solutions and aims to expand its recurring revenue base.
3 min readSenesTech reported preliminary Q3 2026 revenue of $1.1M, a 40% sequential and 55% year-over-year increase, marking its highest quarterly revenue. The company expects continued growth in e-commerce and B2B sectors, with final results to be released in November 2026.
2 min readSenesTech (SNES) presented a new commercial strategy at the Lytham Partners Fall 2026 Investor Conference, focusing on rodent birth control products. The company reported record Q2 2026 revenue of $770,000, up 56% sequentially, with a 76.6% gross margin. Management highlighted growth in e-commerce, Amazon sales, and subscription revenue, aiming for a $1.8B to $2B U.S. market and a $4.5B global market.
2 min readEdell Michael (Chief Executive Officer) purchased 2,000 shares of SenesTech, Inc. (SNES) at $0.64 on 2026-09-28.
1 min readEdell Michael (Chief Executive Officer) purchased 1,000 shares of SenesTech, Inc. (SNES) at $0.84 on 2026-09-14.
1 min readEdell Michael (Chief Executive Officer) purchased 2,000 shares of SenesTech, Inc. (SNES) at an average of $0.87 ($0.85–$0.89) across 2 trades on 2026-09-09.
1 min readEdell Michael (Chief Executive Officer) purchased 1,000 shares of SenesTech, Inc. (SNES) at $1.21 on 2026-08-14.
1 min read
